Leading Fund Manager Joins Valens GroWorks
[ad_1]
Valens GroWorks Corp. (CSE:VGW, OTC:MYMSF) (the “Company” or “Valens”), a multi-licensed, vertically built-in supplier of hashish services targeted on numerous proprietary extraction methodologies, distillation, cannabinoid isolation and purification, in addition to related high quality testing is happy to announce that they’ve employed Everett Knight as Executive Vice President, Strategy & Investments.
Valens GroWorks Corp. (CSE:VGW, OTC:MYMSF) (the “Company” or “Valens”), a multi-licensed, vertically built-in supplier of hashish services targeted on numerous proprietary extraction methodologies, distillation, cannabinoid isolation and purification, in addition to related high quality testing is happy to announce that they’ve employed Everett Knight as Executive Vice President, Strategy & Investments.
Mr. Knight has analyzed a whole lot of hashish firms and toured numerous amenities globally. He has managed one of many solely institutional funding mandates targeted on the hashish trade. His funding expertise within the sector started in 2014 and since that point, he has accrued an intensive understanding of the trade, laws, subsectors, and the businesses concerned on this quick rising area.
“Of all the companies I have evaluated over the past five years Valens has incredible potential and I’m proud to join an experienced team that is on the cutting edge of the cannabis industry,” stated Mr. Knight, Valens Executive Vice President, Strategy & Investments.
“Everett is one of the leading Cannabis Portfolio Managers and has an exceptional investment track record with an in depth knowledge of the cannabis industry,” stated Valens CEO Tyler Robson. “At Valens we strive to be the best in class premium extraction company globally and the addition of Everett will augment our top performing team”
About Valens GroWorks
Valens GroWorks Corp. is a research-driven, vertically built-in Canadian hashish firm targeted on downstream secondary extraction methodology, distillation and cannabinoid isolation and purification, in addition to related high quality testing with three wholly-owned subsidiaries situated in and round Kelowna, BC. Subsidiary Valens Agritech (“VAL”) holds a license to domesticate hashish and produce hashish oil beneath the Cannabis Act, in addition to a license to conduct analytical testing for the hashish trade. VAL at present has provide agreements with numerous main producers throughout Canada. Subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited hashish testing lab offering sector-leading analytical providers and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence for Plant Based Science. Subsidiary Valens Farms is within the means of changing into a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) requirements, making certain the product from this facility may be exported wherever on this planet the place Cannabis is nationally authorized for medical or grownup utilization functions. For extra data, please go to http://valensgroworks.com. The Company’s investor deck may be discovered particularly at http://valensgroworks.com/investors/
Notice relating to Forward Looking Statements
This information launch incorporates sure “forward-looking statements” inside the which means of such statements beneath relevant securities regulation. Forward-looking statements are regularly characterised by phrases corresponding to “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and different comparable phrases, or statements that sure occasions or circumstances “may” or “will” happen. These statements are solely predictions. Various assumptions have been utilized in drawing the conclusions or making the projections contained within the forward-looking statements all through this information launch. Forward-looking statements are based mostly on the opinions and estimates of administration on the date the statements are made and are topic to a wide range of dangers and uncertainties and different elements that might trigger precise occasions or outcomes to vary materially from these projected within the forward-looking statements. The Corporation is beneath no obligation, and expressly disclaims any intention or obligation, to replace or revise any forward-looking statements, whether or not because of new data, future occasions or in any other case, besides as expressly required by relevant regulation.
The CSE or different regulatory authority has not reviewed, permitted or disapproved the contents of this press launch. We search Safe Harbour.
SOURCE Valens GroWorks Corp.
Click here to connect with Valens GroWorks Corp (CSE:VGW, OTC:MYMSF) for an Investor Presentation.
[ad_2]